Thursday, 6 February 2025
11.15 - 17.15

University Hospital Basel
Kleiner Hörsaal, Zentrum für Lehre und Forschung (ZLF)

Dear colleagues

Clinical research is constantly facing new challenges, especially in the development of innovative therapies for diseases that are not necessarily the focus of attention. These include, in particular, neglected diseases that affect millions of people worldwide.

For the scientific kick-off of this year's Clinical Research Day, we are delighted to welcome Prof. Jennifer Keiser. Prof Keiser is Head of the Helminth Drug Development Unit at the Swiss Tropical and Public Health Institute (Swiss TPH) and Professor of Neglected Tropical Diseases at the University of Basel. Her research focusses on the development of new drugs against parasitic worm infections, which affect over 1.5 billion people worldwide.

Prof Keiser has conducted phase 1-3 clinical trials in various endemic regions such as Côte d'Ivoire, Laos and Tanzania and has contributed significantly to the fight against these diseases through her international collaborations.

She will demonstrate how cutting-edge research is driving new therapeutic approaches and what challenges still exist to sustainably improve health in affected regions.

The subsequent scientific programme will focus on the department's young researchers, who will present their latest research work in oral, rapid-fire and poster presentations. A scientific jury will select the three best oral presenatations and the three best posters. The best rapid-fire presentation will be identified by public voting.

At the end, we will meet for an apero riche, the award ceremony and the opportunity for informal exchange and networking.

We are looking forward to a varied overview of current clinical research projects and an exciting and inspiring research day.

Christiane Pauli-Magnus and Niklaus Labhardt (Co-Directors, DKF)
Lars Hemkens (Senior Scientist, DKF)

Call for abstracts

Submission deadline: 30 November 2024

Guidelines for submission

• Please submit your abstract online. Unfortunately we cannot accept abstracts submitted by e-mail.
• The abstracts must be written in English.
• Please make sure that the name, address and e-mail address of the contact person are complete and correct.
• Please structure the abstract as follows:
  (1) Introduction
  (2) Methods
  (3) Results
  (4) Conclusions
• The abstract should contain results of a clinical study (final or interim analysis).
• The text should not be longer than one A4 page.
• Use only common abbreviations. These must be written out in full when first used. Please do not use abbreviations in the title.
• The results of the clinical trial should not have been published in a journal at the time of submission (accepted or in press is possible).
• After successful submission of your abstract you will receive an e-mail confirmation with a reference number of your abstract (for further inquiries and follow-up correspondence). If you do not receive a confirmation, please contact us immediately via e-mail.
• The jury will decide whether the submitted contribution is accepted and should be presented as a short lecture or poster.
• Authors will be notified of the scientific jury's decision via e-mail by 20 December 2024.